In summary, our study demonstrates that TGFβ1 upregulates tricellulin to promote CRC progression, and that tricellulin activates the TGFβ1/SMAD2/3 signaling pathway, further driving CRC progression. The gene discussed is SMAD2; the disease is colorectal carcinoma.